Sources and sequelae of bacterial contamination of hematopoietic stem cell components: Implications for the safety of hematotherapy and graft engineering

Transfusion

Volumn 36, Issue 9, 1996, Pages 782-788

  Webb, I J ^a   Coral, F S ^a   Andersen, J W ^a   Elias, A D ^b   Finberg, R W ^b   Nadler, L M ^b   Ritz, J ^b   Anderson, K C ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; CELL SELECTION; CRYOPRESERVATION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; INFECTION RISK; LYMPHOCYTE SUBPOPULATION; MONONUCLEAR CELL; RISK FACTOR; RISK MANAGEMENT;

EID: 0029848814     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36996420753.x     Document Type: Article

References (37)

1. Tedder RS, Zuckerman MA, Goldstone AH, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995;346:137-40.
2. Anderson KC, Lew MA, Gorgone BC, et al. Transfusion-related sepsis after prolonged platelet storage. Am J Med 1986;81:405-11.
3. Goldman M, Blajchtnan MA. Blood product-associated bacterial sepsis. Transfus Med Rev 1991;5:73-83.
4. Anderson KC. Bacterial contamination of platelets. Transfus Sci 1993;14:159-62.
5. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228-33.
6. Illert WE, Sanger W, Weise W. Bacterial contamination of single-donor blood components. Transfus Med 1995;5:57-61.
7. Borden CW, Hall WH. Fatal transfusion reactions from massive bacterial contamination of blood. N Engl J Med 1951;245:760-5.
8. Braude AJ, Sanford JP, Bartlett JE, Mallery OT Jr. Effects and clinical significance of bacterial contaminants in transfused blood. J Lab Clin Med 1952;39:902-16.
9. Braude AI, Williams D, Siemienski J, Murphy R. Shock-like state due to transfusion of blood contaminated with gram-negative bacilli. Arch Intern Med 1953;92:75-84.
10. Stevens AR, Legg JS, Henry BS, et al. Fatal transfusion reactions from contamination of stored blood by cold growing bacteria. Ann Intern Med 1953;39:1228-39.
11. Tipple MA, Bland LA, Murphy JJ, et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 1990;30:207-13.
12. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8.
13. Rowley SD, Davis J, Dick J, et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Transfusion 1988;28:109-12.
14. D'Antonio D, Iacone A, Fioritoni G, et al. Detection of bacterial contamination in bone marrow graft. Haematologica 1991;76(Suppl 1):44-5.
15. Lazarus HM, Magalhaes-Silverman M, Fox RM, et al. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991;7:241-6.
16. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
17. Schwella N, Zimmermann R, Heuft HG, et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994;67:32-5.
18. Prince HM, Page SR, Keating A, et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87-91.
19. Anderson KC, Ritz J, Takvorian T, et al. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood 1987;69:597-604.
20. Takvorian T, Canellos GP, Ritz J, et al. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 1987;316:1499-505.
21. Pedrazzini A, Freedman AS, Andersen J, et al. Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood 1989;74:2203-11.
22. Anderson KC, Soiffer R, DeLage R, et al. T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood 1990;76:235-44.
23. Freedman AS, Takvorian T, Anderson KC, et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990;8:784-91.
24. Anderson KC, Barut BA, Ritz J, et al. Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 1991;77:712-20.
25. Freedman AS, Ritz J, Neuberg D, et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991;77:2524-9.
26. Anderson KC. The role of the blood bank in hematopoietic stem cell transplantation. Transfusion 1992;32:272-85.
27. Robertson MJ, Soiffer RJ, Freedman AS, et al. Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia. Blood 1992;79:2229-36.
28. Soiffer RJ, Murray C, Mauch P, et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 1992;10:1191-200.
29. Anderson KC, Andersen J, Soiffer R, et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993;82:2568-76.
30. Freedman AS, Takvorian T, Neuberg D, et al. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J Clin Oncol 1993;11:931-6.
31. Soiffer RJ, Roy DC, Gonin R, et al. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant 1993;12:243-51.
32. Anderson KC. Malignant cell purging: monoclonal antibodies. In: Lasky LC, Warkentin PI, eds. Marrow and stem cell processing for transplantation. Bethesda: American Association of Blood Banks, 1995:103-22.
33. Elias AD, Ayash L, Anderson KC, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992;79:3036-44.
34. Webb IJ, Eickhoff CE, Elias AD, et al. Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for timing and yield of hematopoietic progenitor cell collections. Transfusion 1996;36:160-7.
35. Dzieczkowski JS, McGonigal M, Cook J, et al. A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and Cobe Spectra. Transfus Sci 1995;16:71-7.
36. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
37. Mehta CR, Patel NR. A network algorithm for performing Fisher's Exact Test in R x C contingency tables. J Am Stat Assoc 1983;78:427-34.